Last update 08 May 2025
Dojin Iyaku-Kako Co., Ltd.

Dojin Iyaku-Kako Co., Ltd.

Private Company|1946|Tokyo-to, Japan|
www.dojin-ph.co.jp

Overview

Tags

Nervous System Diseases
Congenital Disorders
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Endocrinology and Metabolic Disease1
Infectious Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
COXs(Cyclooxygenases)1

Related

1
Drugs associated with Dojin Iyaku-Kako Co., Ltd.
Diclofenac Sodium
Target
COXs
Mechanism
COX inhibitors
Active Org.
Amzell Ltd.Amzell Ltd.
 [+13]
Originator Org.
Novartis Pharma AG
Active Indication
Bursitis [+24]
Inactive Indication
Actinic Keratosis [+10]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date08 Aug 1973
100 Clinical Results associated with Dojin Iyaku-Kako Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Dojin Iyaku-Kako Co., Ltd.
Login to view more data
5
Literatures (Medical) associated with Dojin Iyaku-Kako Co., Ltd.
01 Jan 2020International Journal of Human Culture Studies
Correlation between “Pointing and Calling” method in manufacturing and degree of fatigue at a pharmaceutical manufacturing plant
01 Jan 2019International Journal of Human Culture Studies
Flood control measures at pharmaceutical manufacturing plants
Oyo Yakuri
Absorption of bergenin from rat's stomach and small intestine
100 Deals associated with Dojin Iyaku-Kako Co., Ltd.
Login to view more data
100 Translational Medicine associated with Dojin Iyaku-Kako Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Diclofenac Sodium
 ( COXs )		Pain
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free